Cargando…
Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic
A rapid spread of different strains of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented pandemic. Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, the medical body has encountered major obstacles concerning disease management at differe...
Autores principales: | Haddad, Isabelle, Kozman, Kathia, Kibbi, Abdul-Ghani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578570/ https://www.ncbi.nlm.nih.gov/pubmed/36267954 http://dx.doi.org/10.3389/falgy.2022.809646 |
Ejemplares similares
-
Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous Urticaria
por: Ridge, Katie, et al.
Publicado: (2021) -
Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
por: García-Gómez, Elizabeth, et al.
Publicado: (2022) -
Urticaria and mimickers of urticaria
por: Fok, Jie Shen, et al.
Publicado: (2023) -
Chronic Urticaria: The Need for Improved Definition
por: Gómez, R. Maximiliano, et al.
Publicado: (2022) -
Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023)